Passion Struck with John R. Miles cover image

Julie Fleshman on How PanCAN Is Raising the Pancreatic Cancer Survival Rate EP 322

Passion Struck with John R. Miles

00:00

The Challenges of Pancreatic Cancer Treatment

Pancreatic cancer is historically a tough disease. Most phase III clinical trials have not proven to be successful. Pan-Can has launched a clinical trial called Precision Promise, and it's an adaptive clinical trial platform. And because of the way that statistical methodology is done in this adaptive trial, it allows you to enroll fewer patients in each of those investigational studies.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app